50 related articles for article (PubMed ID: 16895483)
21. Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer.
Konecny G; Untch M; Pihan A; Kimmig R; Gropp M; Stieber P; Hepp H; Slamon D; Pegram M
Clin Cancer Res; 2001 Jun; 7(6):1743-9. PubMed ID: 11410515
[TBL] [Abstract][Full Text] [Related]
22. Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma.
Dorn J; Harbeck N; Kates R; Magdolen V; Grass L; Soosaipillai A; Schmalfeldt B; Diamandis EP; Schmitt M
Biol Chem; 2006 Aug; 387(8):1121-8. PubMed ID: 16895483
[TBL] [Abstract][Full Text] [Related]
23. Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer.
Harbeck N; Kates RE; Gauger K; Willems A; Kiechle M; Magdolen V; Schmitt M
Thromb Haemost; 2004 Mar; 91(3):450-6. PubMed ID: 14983219
[TBL] [Abstract][Full Text] [Related]
24. Human tissue kallikrein gene family: applications in cancer.
Obiezu CV; Diamandis EP
Cancer Lett; 2005 Jun; 224(1):1-22. PubMed ID: 15911097
[TBL] [Abstract][Full Text] [Related]
25. Human tissue kallikreins: the cancer biomarker family.
Paliouras M; Borgono C; Diamandis EP
Cancer Lett; 2007 Apr; 249(1):61-79. PubMed ID: 17275179
[TBL] [Abstract][Full Text] [Related]
26. Kallikreins, steroid hormones and ovarian cancer: is there a link?
Yousef GM; Diamandis EP
Minerva Endocrinol; 2002 Sep; 27(3):157-66. PubMed ID: 12091791
[TBL] [Abstract][Full Text] [Related]
27. Human tissue kallikreins: a new enzymatic cascade pathway?
Yousef GM; Diamandis EP
Biol Chem; 2002; 383(7-8):1045-57. PubMed ID: 12437087
[TBL] [Abstract][Full Text] [Related]
28. Human tissue kallikreins: physiologic roles and applications in cancer.
Borgoño CA; Michael IP; Diamandis EP
Mol Cancer Res; 2004 May; 2(5):257-80. PubMed ID: 15192120
[TBL] [Abstract][Full Text] [Related]
29. Evolving role of uPA/uPAR system in human cancers.
Dass K; Ahmad A; Azmi AS; Sarkar SH; Sarkar FH
Cancer Treat Rev; 2008 Apr; 34(2):122-36. PubMed ID: 18162327
[TBL] [Abstract][Full Text] [Related]
30. The plasminogen activator inhibitor "paradox" in cancer.
Binder BR; Mihaly J
Immunol Lett; 2008 Jun; 118(2):116-24. PubMed ID: 18495253
[TBL] [Abstract][Full Text] [Related]
31. Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.
Dorn J; Beaufort N; Schmitt M; Diamandis EP; Goettig P; Magdolen V
Crit Rev Clin Lab Sci; 2014 Apr; 51(2):63-84. PubMed ID: 24490956
[TBL] [Abstract][Full Text] [Related]
32. The kallikrein world: an update on the human tissue kallikreins.
Paliouras M; Diamandis EP
Biol Chem; 2006 Jun; 387(6):643-52. PubMed ID: 16800725
[TBL] [Abstract][Full Text] [Related]
33. Human tissue kallikreins: a family of new cancer biomarkers.
Diamandis EP; Yousef GM
Clin Chem; 2002 Aug; 48(8):1198-205. PubMed ID: 12142373
[TBL] [Abstract][Full Text] [Related]
34. Cellular distribution of human tissue kallikreins: immunohistochemical localization.
Petraki CD; Papanastasiou PA; Karavana VN; Diamandis EP
Biol Chem; 2006 Jun; 387(6):653-63. PubMed ID: 16800726
[TBL] [Abstract][Full Text] [Related]
35. The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.
Clements JA; Willemsen NM; Myers SA; Dong Y
Crit Rev Clin Lab Sci; 2004; 41(3):265-312. PubMed ID: 15307634
[TBL] [Abstract][Full Text] [Related]
36. Tissue kallikreins: new players in normal and abnormal cell growth?
Yousef GM; Diamandis EP
Thromb Haemost; 2003 Jul; 90(1):7-16. PubMed ID: 12876620
[TBL] [Abstract][Full Text] [Related]
37. Human tissue kallikreins and testicular cancer.
Luo LY; Yousef G; Diamandis EP
APMIS; 2003 Jan; 111(1):225-32; discussion 232-3. PubMed ID: 12752266
[TBL] [Abstract][Full Text] [Related]
38. The emerging roles of human tissue kallikreins in cancer.
Borgoño CA; Diamandis EP
Nat Rev Cancer; 2004 Nov; 4(11):876-90. PubMed ID: 15516960
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value and biological role of the kallikrein-related peptidases in human malignancies.
Mavridis K; Scorilas A
Future Oncol; 2010 Feb; 6(2):269-85. PubMed ID: 20146586
[TBL] [Abstract][Full Text] [Related]
40. An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers.
Yousef GM; Diamandis EP
Clin Biochem; 2003 Sep; 36(6):443-52. PubMed ID: 12951170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
